Advertisement
Canada markets closed
  • S&P/TSX

    24,471.17
    +168.87 (+0.69%)
     
  • S&P 500

    5,815.03
    +34.98 (+0.61%)
     
  • DOW

    42,863.86
    +409.76 (+0.97%)
     
  • CAD/USD

    0.7250
    -0.0020 (-0.27%)
     
  • CRUDE OIL

    73.79
    -1.77 (-2.34%)
     
  • Bitcoin CAD

    89,484.66
    +3,143.81 (+3.64%)
     
  • XRP CAD

    0.74
    +0.01 (+1.20%)
     
  • GOLD FUTURES

    2,672.00
    -4.30 (-0.16%)
     
  • RUSSELL 2000

    2,234.41
    +45.99 (+2.10%)
     
  • 10-Yr Bond

    4.0730
    -0.0230 (-0.56%)
     
  • NASDAQ

    18,342.94
    +60.94 (+0.33%)
     
  • VOLATILITY

    20.53
    +0.07 (+0.34%)
     
  • FTSE

    8,250.36
    -3.29 (-0.04%)
     
  • NIKKEI 225

    39,605.80
    +224.90 (+0.57%)
     
  • CAD/EUR

    0.6639
    -0.0003 (-0.05%)
     

How This Amgen Rival Is Taking On The Company's $28 Billion Acquisition

How This Amgen Rival Is Taking On The Company's $28 Billion Acquisition

Viridian Therapeutics stock jumped Tuesday after unveiling promising results for its Amgen-rivaling eye disease treatment.